Method of blocking 5HT without effect on alpha receptors with 1-loweralkyl-6-straight chain alkyl-8 beta -hydroxycycloalkyloxycarbonylergolines.
4-hydroxycyclohexyl 1-isopropyl-9,10-dihydro-lysergate for the treatment of migraine